Intuitive Surgical, Inc. · NASDAQ:ISRG
Intuitive Surgical — J.P. Morgan Healthcare Conference 2026
27 slides from Intuitive Surgical's conference presentation, Jan 14, 2026
Slide 1: J.P. Morgan Healthcare Conference 2026
J.P. Morgan Healthcare Conference 2026 Dave Rosa Chief Executive Officer 14 January 2026 © 2026 Intuitive Surgical Operations, Inc. All rights reserved.
Slide 2: Cautionary note on forward-looking statements
Cautionary note on forward-looking statements This presentation contains “forward-looking prices a sufficient supply of materials, parts, and factors can be found in Intuitive’s Annual Report on statements” as defined in the Private Securities components; public health crises or epidemic Form 10-K,
Slide 3: Our mission and vision
Our mission We believe that minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints. Our vision We envision a future of care that is less invasive and profoundly better, where diseases are identif
Slide 4: The Quintuple Aim
The Quintuple Aim Where we are focused with our customers Improve Enhance patient Improve care Lower total Expand access outcomes experience team experience cost of care to care Surgical-site infections Outpatient vs. inpatient Training Direct costs Education and empowerment Complications Conversion
Slide 5: Listen. Observe. Learn. Build. Iterate.
Listen. Observe. Learn. Build. Iterate. 30 years of innovating for minimally invasive care with customers, physicians, care teams Da Vinci Da Vinci S Da Vinci Si Da Vinci X Da Vinci Xi Da Vinci 5 Da Vinci SP Ion © 2026 Intuitive Surgical Operations, Inc. All rights reserved.
Slide 6: Patients first, always.
Patients first, always. 20.4M+ Patients4 Serving patients globally in 70+ countries OUS OUS OUS 17% 23% 35% US Europe Asia 2005 1 2025 3 Rest of world 2015 2 US US US 83% 77% 65% ’00 ’01 ’02 ’03 ’04 ’05 ’06 ’07 ’08 ’09 ’10 ’11 ’12 ’13 ’14 ’15 ’16 ’17 ’18 ’19 ’20 ’21 ’22 ’23 ’24 ’25 1. Procedures per
Slide 7: Procedures and systems in 2025 and to date
3.2M+ 1,900+ 4,000+ Procedures performed on Intuitive systems Intuitive systems in 2025 placed in 2025 Peer-reviewed articles published in 20252 3.0M+ 55K+ 140K+ 1,610+ 100+ 190+ Multi-port Single-port Ion Multi-port Single-port Ion 20.4M+ 12,000+ 48,000+ Procedures performed on Intuitive systems in
Slide 8: Continue to pursue great customer experiences
Continue to pursue great customer experiences NPS classification 2025 Why? › World class: 70+ 76 Our products work— Excellent: 50–69 features and reliability Good: 0–50 Teams are aligned to our customers’ missions Net promoter score (NPS) Focus on data Address difficult challenges head-on JD Pow
Slide 9: 2025 Commentary
2025 Commentary Objectives Challenges Areas of Results Innovation Dynamic trade environment strength Full launch of dV5 platform with regional clearances and follow-on feature releases. China pricing and competitive conditions U.S. general surgery 19% Total procedure growth YoY Da Vinci 5 broad laun
Slide 10: Da Vinci platforms
Da Vinci platforms © 2026 Intuitive Surgical Operations, Inc. All rights reserved.
Slide 11: Strong global da Vinci 5 launch
Strong global da Vinci 5 launch U.S., Korea, Japan, and Europe clearances 270,000+ Procedures performed to date 1,200+ Systems installed 10,400+ Surgeons using da Vinci 5 11% 1. Utilization calculated as of Q4 2025 Higher utilization than Xi in the US 1 Vinci 5 Source: Intuitive 2025 earnings estima
Slide 12: Improving surgical senses and procedural efficiency
Improving surgical senses and procedural efficiency Outcomes and learning Surgeon autonomy Instrument innovation Visualization 3D Models Force Feedback Insufflation sensing Vessel Sealer Curved Force gauge Head-in UI *Force gauge movement represents a real-time relative scale of force applied at the
Slide 13: Improving surgical senses and procedural efficiency
Improving surgical senses and procedural efficiency Future imaging capabilities* Future instrumentation* Future imaging capabilities* Molecules Multifire Clip Applier Real-time tissue oxygenation *These products and technologies are still in development, not 510(k) cleared and the safety or effectiv
Slide 14: The digital journey
The digital journey Augmented dexterity No-fly zone Instrument control Intraoperative guidance Telecollaboration Force gauge Telesurgery Meaningful insights Case Insights Force Feedback SimNow Good data Da Vinci 5 Outcomes © 2026 Intuitive Surgical Operations, Inc. All rights reserved.
Slide 15: My Intuitive+
My Intuitive+ SimNow Telepresence Case Insights Build proficiency in a Enable real-time case observation, Extract objective insights from surgery consequence-free environment collaboration, and mentoring to help surgeons elevate their skills SimNow Telepresence Case Insights attempts sessions report
Slide 16: Da Vinci SP
Da Vinci SP New indications and countries in 2025 SP SureForm Stapler Future Vessel Sealer Extend* United States Transanal local excision Inguinal hernia Cholecystectomy Appendectomy Nipple-sparing mastectomy Greece Czech Republic Poland Turkey UAE Saudi Arabia Chile • This product is still in devel
Slide 17: Da Vinci SP
Da Vinci SP Procedures Installed base Utilization 87% 55K+ 39% 370+ 29% YoY Growth YoY Growth YoY Growth 180+ 110+ 60+ 5K+ 2020 2021 2022 2023 2024 2025 2020 2021 2022 2023 2024 2025 2020 2021 2022 2023 2024 2025 Source: Intuitive 2025 earnings estimate. © 2026 Intuitive Surgical Operations, Inc. Al
Slide 18: Da Vinci line of sight
Da Vinci ~23M Soft tissue surgical procedures January 2026 We define our line of sight ~20M as procedure segments Minimally invasive surgical procedures where we currently have products, clearances, and supportive economics.1 ~9M Line of sight 1. Line of sight: Estimated portion of targeted procedur
Slide 19: Ion
Ion © 2026 Intuitive Surgical Operations, Inc. All rights reserved.
Slide 20: Ion
Ion Procedures Installed base Utilization 51% 24% 9% YoY Growth YoY Growth YoY Growth 140K+ 990+ 160+ 1K+ 30+ 80+ 2020 2021 2022 2023 2024 2025 2020 2021 2022 2023 2024 2025 2020 2021 2022 2023 2024 2025 Source: Intuitive 2025 earnings estimate. © 2026 Intuitive Surgical Operations, Inc. All rights
Slide 21: Significant improvement in lung cancer survival is our north star
977 Significant improvement 088 in lung cancer survival is our north star 199 200+ Detection to decision Days 1,2 Detection Evaluation Diagnosis Treatment Screening or incidental finding Nodule detection Multispecialty Watch care team and wait Lung biopsy EBUS cancer ROSEwith concomitant staging Pat
Slide 22: Significant improvement in lung cancer survival is our north star
5 Significant improvement06 in lung cancer survival is our north 17 star 28 Detection to Decision Intervention Intuitive Diagnosis Days North Star Detection Screening or incidental finding Lung biopsy with concomitant 39 40 ROSE Nodule EBUS cancer detection staging 51 Evaluation Pathology Multispeci
Slide 23: Impact of Ion with cone beam CT on earlier diagnosis
Impact of Ion with cone beam CT on earlier diagnosis Stage IA and all primary non-small cell lung cancer (NSCLC) cases at the Comprehensive Cancer Center Zurich over the past 7 years: A breakthrough in early detection Installation of 120 Ion and CBCT 100 Stage 1A diagnosis rate increased by 30 80 pe
Slide 24: Ion line of sight
Ion Lung Cancer COPD January 2026 Therapies under evaluation in the lung We define our line of sight as procedure segments where we currently have products, ~1.5M clearances, and supportive Total addressable market for biopsy (+ROSE and staging2) economics.1 ~0.7M Line of sight with biopsy 1. Line o
Slide 25: 2026 Priorities
2026 Priorities Accelerate access to and quality of minimally invasive care by driving: Platform Procedure Quality and Innovation to growth adoption manufacturing reach more Global expansion of Focus procedure growth Continued focus on patients da Vinci 5, SP, and Ion. by country through product qua
Slide 26: Future innovation
Future innovation Unmet needs Core capabilities The Quintuple Aim © 2026 Intuitive Surgical Operations, Inc. All rights reserved.
Slide 27: intuitive.com
intuitive.com
Intuitive Surgical — J.P. Morgan Healthcare Conference 2026 on 6ix